Condition · ICD-10 N18.9

Chronic Kidney Disease

CKD

A gradual loss of kidney function over months or years, often caused by diabetes or hypertension, that can progress to kidney failure.

Chronic kidney disease affects approximately 15% of US adults and is a leading cause of end-stage renal disease. The primary goals of management are to slow progression and prevent cardiovascular complications. ACE inhibitors or ARBs reduce proteinuria and slow progression; SGLT2 inhibitors have demonstrated nephroprotective effects independent of glycemic control.

At a glance
Medications tracked
6
First-line options
Lisinopril, Losartan, Empagliflozin
Related conditions
Type 2 DiabetesHypertensionHeart FailureAnemia

First-line Related Treatments

Commonly associated primary options — verify with your clinician

Primary options
Lisinopril
Lisinopril
Rx
Tablet
Strength 10 mg
NDC 0591-0407-01
Losartan
Losartan
Rx
Tablet
Strength 50 mg
NDC 0310-0271-90
Empagliflozin
Empagliflozin
Rx
Tablet
Strength 10 mg
NDC 0597-0152-07

Short-term / As-needed

Related options for acute or bridging use

Acute or bridging use
Furosemide
Furosemide
Rx
Tablet
Strength 40 mg
NDC 0093-0015-01
Sodium Bicarbonate
Sodium Bicarbonate
OTC
Tablet
Strength 650 mg
NDC 0536-3840-01

Situational

Related options for specific presentations

Specific presentations
Ferrous Sulfate
Ferrous Sulfate
OTC
Tablet
Strength 325 mg
NDC 0536-5880-01

Top treatments tried for Chronic Kidney Disease

Community-driven data · early preview

Lisinopril
1,800 people tried
4.3
Losartan
1,520 people tried
4.1
Empagliflozin
1,240 people tried
4.0
Furosemide
960 people tried
3.8
Help build the dataset — log treatments you've tried, rate what helped, and report side effects.